$GEB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INOVIO PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INOVIO PHARMACEUTICALS, INC.. Get notifications about new insider transactions in INOVIO PHARMACEUTICALS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18 2009 | GEB | INOVIO PHARMACEUTI ... | Rassas Kevin | Sr. VP Business Dev ... | Option Exercise | M | 0.05 | 98,120 | 5,004 | 98,120 | |
| Nov 18 2009 | GEB | INOVIO PHARMACEUTI ... | Rassas Kevin | Sr. VP Business Dev ... | Buy | M | 0.31 | 117,744 | 36,006 | 726,088 | 608.3 K to 726.1 K (+19.35 %) |
| Nov 18 2009 | GEB | INOVIO PHARMACEUTI ... | Rassas Kevin | Sr. VP Business Dev ... | Buy | M | 0.20 | 392,480 | 79,987 | 608,344 | 215.9 K to 608.3 K (+181.82 %) |
| Nov 18 2009 | GEB | INOVIO PHARMACEUTI ... | Rassas Kevin | Sr. VP Business Dev ... | Buy | M | 0.05 | 98,120 | 5,004 | 215,864 | 117.7 K to 215.9 K (+83.33 %) |
| Oct 29 2009 | GEB | INOVIO PHARMACEUTI ... | Williams David J | Director | Option Exercise | A | 1.20 | 75,000 | 90,000 | 75,000 | |
| Oct 28 2009 | GEB | INOVIO PHARMACEUTI ... | Wells Keith H | Director | Option Exercise | A | 1.20 | 75,000 | 90,000 | 75,000 | |
| Oct 02 2009 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 1.57 | 75,000 | 117,750 | 75,000 | |
| Oct 02 2009 | GEB | INOVIO PHARMACEUTI ... | NG TEE KHIANG | Director | Option Exercise | A | 1.57 | 75,000 | 117,750 | 75,000 | |
| Oct 02 2009 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 1.57 | 75,000 | 117,750 | 75,000 | |
| Oct 02 2009 | GEB | INOVIO PHARMACEUTI ... | Rassas Kevin | Sr. VP Business Dev ... | Option Exercise | A | 1.57 | 120,000 | 188,400 | 120,000 | |
| Oct 02 2009 | GEB | INOVIO PHARMACEUTI ... | Sardesai Niranjan | Sr. VP Research & D ... | Option Exercise | A | 1.57 | 120,000 | 188,400 | 120,000 | |
| Oct 02 2009 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | A | 1.57 | 280,000 | 439,600 | 280,000 | |
| Oct 02 2009 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 1.57 | 85,000 | 133,450 | 85,000 | |
| Oct 02 2009 | GEB | INOVIO PHARMACEUTI ... | Fons Michael | VP, Corporate Devel ... | Option Exercise | A | 1.57 | 40,000 | 62,800 | 40,000 | |
| Oct 02 2009 | GEB | INOVIO PHARMACEUTI ... | DHILLON PUNIT | VP, Finance & Opera ... | Option Exercise | A | 1.57 | 75,000 | 117,750 | 75,000 | |
| Oct 02 2009 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & Chairma ... | Option Exercise | A | 1.57 | 125,000 | 196,250 | 125,000 | |
| Jul 01 2009 | GEB | INOVIO PHARMACEUTI ... | White Cheryl Jo | Chief Medical Offic ... | Option Exercise | M | 0.21 | 98,120 | 20,605 | 98,120 | |
| Jul 01 2009 | GEB | INOVIO PHARMACEUTI ... | White Cheryl Jo | Chief Medical Offic ... | Option Exercise | M | 0.03 | 98,120 | 2,944 | 98,120 | |
| Apr 09 2009 | GEB | INOVIO PHARMACEUTI ... | NG TEE KHIANG | Director | Option Exercise | A | 0.38 | 30,000 | 11,400 | 30,000 | |
| Dec 10 2008 | GEB | INOVIO PHARMACEUTI ... | Fons Michael | VP, Corporate Devel ... | Option Exercise | A | 0.50 | 20,000 | 10,000 | 20,000 | |
| Dec 10 2008 | GEB | INOVIO PHARMACEUTI ... | DHILLON PUNIT | VP, Finance & Opera ... | Option Exercise | A | 0.50 | 70,000 | 35,000 | 70,000 | |
| Dec 10 2008 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.50 | 40,000 | 20,000 | 40,000 | |
| Dec 10 2008 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Option Exercise | A | 0.50 | 100,000 | 50,000 | 100,000 | |
| Dec 10 2008 | GEB | INOVIO PHARMACEUTI ... | Chong Chin Cheong | Director | Option Exercise | A | 0.50 | 30,000 | 15,000 | 30,000 | |
| Aug 18 2008 | GEB | INOVIO PHARMACEUTI ... | HEPPELL JAMES L | Director | Option Exercise | A | 1.03 | 75,000 | 77,250 | 75,000 | |
| Jul 09 2008 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 1.06 | 60,000 | 63,600 | 60,000 | |
| Jul 09 2008 | GEB | INOVIO PHARMACEUTI ... | Fons Michael | VP, Corporate Devel ... | Option Exercise | A | 1.06 | 60,000 | 63,600 | 60,000 | |
| Jul 09 2008 | GEB | INOVIO PHARMACEUTI ... | DHILLON PUNIT | VP, Finance & Opera ... | Option Exercise | A | 1.06 | 60,000 | 63,600 | 60,000 | |
| May 07 2008 | GEB | INOVIO PHARMACEUTI ... | GAN BENG LEE | Director | Option Exercise | A | 0.89 | 30,000 | 26,700 | 30,000 | |
| May 06 2008 | GEB | INOVIO PHARMACEUTI ... | ESMAIL TAZDIN | Director | Option Exercise | A | 0.89 | 15,000 | 13,350 | 15,000 | |
| May 06 2008 | GEB | INOVIO PHARMACEUTI ... | Bandali Riaz Amirali | Director | Option Exercise | A | 0.89 | 15,000 | 13,350 | 15,000 | |
| May 06 2008 | GEB | INOVIO PHARMACEUTI ... | HEPPELL JAMES L | Director | Option Exercise | A | 0.89 | 15,000 | 13,350 | 15,000 | |
| May 06 2008 | GEB | INOVIO PHARMACEUTI ... | Rieder Robert William | Director | Option Exercise | A | 0.89 | 15,000 | 13,350 | 15,000 | |
| May 06 2008 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 0.89 | 15,000 | 13,350 | 15,000 | |
| May 06 2008 | GEB | INOVIO PHARMACEUTI ... | RIETIKER STEPHEN | Director | Option Exercise | A | 0.89 | 15,000 | 13,350 | 15,000 | |
| Feb 01 2008 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.88 | 30,000 | 26,400 | 30,000 | |
| Feb 22 2008 | GEB | INOVIO PHARMACEUTI ... | RIETIKER STEPHEN | Director | Option Exercise | A | 1.05 | 30,000 | 31,500 | 30,000 | |
| Feb 01 2008 | GEB | INOVIO PHARMACEUTI ... | DHILLON PUNIT | VP, Finance & Opera ... | Option Exercise | A | 0.87 | 50,000 | 43,500 | 50,000 | |
| Feb 01 2008 | GEB | INOVIO PHARMACEUTI ... | Fons Michael | VP, Corporate Devel ... | Option Exercise | A | 0.88 | 20,000 | 17,600 | 30,000 | |
| Feb 01 2008 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Option Exercise | P | 0.87 | 75,000 | 65,250 | 75,000 | |
| Feb 01 2008 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Grant | A | 0.00 | 75,000 | 0 | 210,206 | 135.2 K to 210.2 K (+55.47 %) |
| May 08 2007 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Grant | A | 0.00 | 75,000 | 0 | 135,206 | 60.2 K to 135.2 K (+124.57 %) |
| May 08 2007 | GEB | INOVIO PHARMACEUTI ... | HEPPELL JAMES L | Director | Option Exercise | A | 3.75 | 15,000 | 56,250 | 15,000 | |
| May 08 2007 | GEB | INOVIO PHARMACEUTI ... | ESMAIL TAZDIN | Director | Option Exercise | A | 3.75 | 15,000 | 56,250 | 15,000 | |
| May 08 2007 | GEB | INOVIO PHARMACEUTI ... | Bandali Riaz Amirali | Director | Option Exercise | A | 3.75 | 15,000 | 56,250 | 15,000 | |
| May 08 2007 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 3.75 | 15,000 | 56,250 | 15,000 | |
| May 08 2007 | GEB | INOVIO PHARMACEUTI ... | Rieder Robert William | Director | Option Exercise | A | 3.75 | 30,000 | 112,500 | 30,000 | |
| Apr 02 2007 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Sell | J | 0.00 | 75,000 | 0 | 60,206 | 135.2 K to 60.2 K (-55.47 %) |
| Mar 09 2007 | GEB | INOVIO PHARMACEUTI ... | RABUSSAY DIETMAR P | V.P. Research & Dev ... | Option Exercise | A | 3.16 | 25,000 | 79,000 | 25,000 | |
| Mar 09 2007 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 3.16 | 75,000 | 237,000 | 75,000 | |
| Mar 09 2007 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Option Exercise | A | 3.16 | 225,000 | 711,000 | 225,000 | |
| Mar 09 2007 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Grant | A | 0.00 | 75,000 | 0 | 135,206 | 60.2 K to 135.2 K (+124.57 %) |
| Dec 22 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | M | 2.52 | 4,400 | 11,088 | 0 | |
| Dec 22 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Sell | S | 3.20 | 4,400 | 14,080 | 0 | 4.4 K to 0 (-100.00 %) |
| Dec 22 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Buy | M | 2.52 | 4,400 | 11,088 | 0 | -4,400 to 0 (-100.00 %) |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | M | 2.52 | 13,100 | 33,012 | 4,400 | |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | M | 1.24 | 12,500 | 15,500 | 0 | |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | M | 1.00 | 1,875 | 1,875 | 0 | |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | M | 1.08 | 9,375 | 10,125 | 0 | |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | M | 1.64 | 1,875 | 3,075 | 0 | |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | M | 1.88 | 4,375 | 8,225 | 0 | |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Sell | S | 3.20 | 43,100 | 137,920 | 0 | 43.1 K to 0 (-100.00 %) |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Buy | M | 2.52 | 13,100 | 33,012 | 0 | -13,100 to 0 (-100.00 %) |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Buy | M | 1.24 | 12,500 | 15,500 | 0 | -12,500 to 0 (-100.00 %) |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Buy | M | 1.00 | 1,875 | 1,875 | 0 | -1,875 to 0 (-100.00 %) |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Buy | M | 1.08 | 9,375 | 10,125 | 0 | -9,375 to 0 (-100.00 %) |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Buy | M | 1.64 | 1,875 | 3,075 | 0 | -1,875 to 0 (-100.00 %) |
| Dec 21 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Buy | M | 1.88 | 4,375 | 8,225 | 0 | -4,375 to 0 (-100.00 %) |
| Jun 09 2006 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 2.23 | 25,000 | 55,750 | 25,000 | |
| Jun 09 2006 | GEB | INOVIO PHARMACEUTI ... | Bandali Riaz Amirali | Director | Option Exercise | A | 2.23 | 25,000 | 55,750 | 25,000 | |
| Jun 09 2006 | GEB | INOVIO PHARMACEUTI ... | ESMAIL TAZDIN | Director | Option Exercise | A | 2.23 | 25,000 | 55,750 | 25,000 | |
| Jun 09 2006 | GEB | INOVIO PHARMACEUTI ... | THEEUWES FELIX | Director | Option Exercise | A | 2.23 | 25,000 | 55,750 | 25,000 | |
| Jun 09 2006 | GEB | INOVIO PHARMACEUTI ... | HEPPELL JAMES L | Director | Option Exercise | A | 2.23 | 25,000 | 55,750 | 25,000 | |
| Mar 10 2006 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | A | 2.89 | 45,000 | 130,050 | 45,000 | |
| Mar 10 2006 | GEB | INOVIO PHARMACEUTI ... | McHugh George F. III | Vice President, Ope ... | Option Exercise | A | 2.89 | 45,000 | 130,050 | 45,000 | |
| Mar 10 2006 | GEB | INOVIO PHARMACEUTI ... | RABUSSAY DIETMAR P | V.P. Research & Dev ... | Option Exercise | A | 2.89 | 35,000 | 101,150 | 35,000 | |
| Mar 10 2006 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Option Exercise | A | 2.89 | 75,000 | 216,750 | 75,000 | |
| Mar 10 2006 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 2.89 | 45,000 | 130,050 | 45,000 | |
| May 16 2005 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 3.34 | 10,000 | 33,400 | 10,000 | |
| May 16 2005 | GEB | INOVIO PHARMACEUTI ... | Bandali Riaz Amirali | Director | Option Exercise | A | 3.34 | 10,000 | 33,400 | 10,000 | |
| May 16 2005 | GEB | INOVIO PHARMACEUTI ... | HEPPELL JAMES L | Director | Option Exercise | A | 3.34 | 10,000 | 33,400 | 10,000 | |
| May 16 2005 | GEB | INOVIO PHARMACEUTI ... | ESMAIL TAZDIN | Director | Option Exercise | A | 3.34 | 10,000 | 33,400 | 10,000 | |
| May 16 2005 | GEB | INOVIO PHARMACEUTI ... | LARSON EUGENE A | Director | Option Exercise | A | 3.34 | 10,000 | 33,400 | 10,000 | |
| May 16 2005 | GEB | INOVIO PHARMACEUTI ... | THEEUWES FELIX | Director | Option Exercise | A | 3.34 | 10,000 | 33,400 | 10,000 | |
| Mar 01 2005 | GEB | INOVIO PHARMACEUTI ... | RABUSSAY DIETMAR P | V.P. Research & Dev ... | Option Exercise | A | 4.46 | 10,000 | 44,600 | 10,000 | |
| Mar 01 2005 | GEB | INOVIO PHARMACEUTI ... | McHugh George F. III | Vice President, Ope ... | Option Exercise | A | 4.46 | 15,000 | 66,900 | 15,000 | |
| Mar 01 2005 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | A | 4.46 | 20,000 | 89,200 | 20,000 | |
| Mar 01 2005 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 4.46 | 20,000 | 89,200 | 20,000 | |
| Jan 19 2005 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Option Exercise | A | 3.82 | 150,000 | 573,000 | 150,000 | |
| Nov 23 2004 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | M | 1.88 | 625 | 1,175 | 4,375 | |
| Nov 23 2004 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | M | 1.64 | 5,625 | 9,225 | 1,875 | |
| Nov 23 2004 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | M | 1.00 | 5,625 | 5,625 | 1,875 | |
| Nov 23 2004 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | M | 1.08 | 28,125 | 30,375 | 9,375 | |
| Nov 23 2004 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Sell | S | 3.55 | 7,500 | 26,625 | 0 | 7.5 K to 0 (-100.00 %) |
| Nov 23 2004 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Sell | S | 3.50 | 32,500 | 113,750 | 7,500 | 40 K to 7.5 K (-81.25 %) |
| Nov 23 2004 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Buy | M | 1.88 | 625 | 1,175 | 40,000 | 39.4 K to 40 K (+1.59 %) |
| Nov 23 2004 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Buy | M | 1.64 | 5,625 | 9,225 | 39,375 | 33.8 K to 39.4 K (+16.67 %) |
| Nov 23 2004 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Buy | M | 1.00 | 5,625 | 5,625 | 33,750 | 28.1 K to 33.8 K (+20.00 %) |
| Nov 23 2004 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Buy | M | 1.08 | 28,125 | 30,375 | 28,125 | 0 to 28.1 K |
| Nov 15 2004 | GEB | INOVIO PHARMACEUTI ... | RABUSSAY DIETMAR P | V.P. Research & Dev ... | Sell | S | 3.41 | 250 | 853 | 17,386 | 17.6 K to 17.4 K (-1.42 %) |
| Oct 14 2004 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Buy | P | 2.56 | 6,600 | 16,896 | 60,187 | 53.6 K to 60.2 K (+12.32 %) |
| Oct 14 2004 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Buy | P | 2.55 | 400 | 1,020 | 53,587 | 53.2 K to 53.6 K (+0.75 %) |
| Oct 14 2004 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Buy | P | 2.44 | 3,000 | 7,320 | 53,187 | 50.2 K to 53.2 K (+5.98 %) |
| Sep 20 2004 | GEB | INOVIO PHARMACEUTI ... | HEPPELL JAMES L | Director | Option Exercise | P | 8.80 | 1,029 | 9,055 | 1,029 | |
| Sep 20 2004 | GEB | INOVIO PHARMACEUTI ... | HEPPELL JAMES L | Director | Buy | P | 11,764.70 | 2 | 23,529 | 2 | 0 to 2 |
| Sep 16 2004 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Option Exercise | P | 8.80 | 514 | 4,523 | 514 | |
| Sep 16 2004 | GEB | INOVIO PHARMACEUTI ... | GOODENEW ROBERT S | V.P. Corporate Deve ... | Buy | P | 5,882.35 | 1 | 5,882 | 1 | 0 to 1 |
| Sep 16 2004 | GEB | INOVIO PHARMACEUTI ... | ESMAIL TAZDIN | Director | Option Exercise | P | 8.80 | 1,029 | 9,055 | 1,029 | |
| Sep 16 2004 | GEB | INOVIO PHARMACEUTI ... | ESMAIL TAZDIN | Director | Buy | P | 11,764.70 | 2 | 23,529 | 2 | 0 to 2 |
| Sep 16 2004 | GEB | INOVIO PHARMACEUTI ... | Bandali Riaz Amirali | Director | Option Exercise | P | 8.80 | 1,029 | 9,055 | 1,029 | |
| Sep 16 2004 | GEB | INOVIO PHARMACEUTI ... | Bandali Riaz Amirali | Director | Buy | P | 11,764.70 | 2 | 23,529 | 2 | 0 to 2 |
| Sep 16 2004 | GEB | INOVIO PHARMACEUTI ... | RABUSSAY DIETMAR P | V.P. Research & Dev ... | Option Exercise | P | 8.80 | 514 | 4,523 | 514 | |
| Sep 16 2004 | GEB | INOVIO PHARMACEUTI ... | RABUSSAY DIETMAR P | V.P. Research & Dev ... | Buy | P | 5,882.35 | 1 | 5,882 | 1 | 0 to 1 |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Option Exercise | P | 8.80 | 1,029 | 9,055 | 1,029 | |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Buy | P | 11,764.70 | 2 | 23,529 | 2 | 0 to 2 |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | THEEUWES FELIX | Director | Option Exercise | P | 8.80 | 1,029 | 9,055 | 1,029 | |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | THEEUWES FELIX | Director | Buy | P | 11,764.70 | 2 | 23,529 | 2 | 0 to 2 |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | McHugh George F. III | Vice President, Ope ... | Option Exercise | P | 8.80 | 514 | 4,523 | 514 | |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | McHugh George F. III | Vice President, Ope ... | Buy | P | 5,882.35 | 1 | 5,882 | 1 | 0 to 1 |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | LARSON EUGENE A | Director | Option Exercise | P | 8.80 | 1,544 | 13,587 | 1,544 | |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | LARSON EUGENE A | Director | Buy | P | 17,647.10 | 3 | 52,941 | 3 | 0 to 3 |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | P | 8.80 | 1,544 | 13,587 | 1,544 | |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Buy | P | 17,647.10 | 3 | 52,941 | 3 | 0 to 3 |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | P | 8.80 | 514 | 4,523 | 514 | |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | P | 5,882.35 | 1 | 5,882 | 1 | 0 to 1 |
| Aug 17 2004 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 0.93 | 20,000 | 18,600 | 20,000 | |
| Aug 17 2004 | GEB | INOVIO PHARMACEUTI ... | LARSON EUGENE A | Director | Option Exercise | A | 0.93 | 20,000 | 18,600 | 20,000 | |
| Aug 17 2004 | GEB | INOVIO PHARMACEUTI ... | THEEUWES FELIX | Director | Option Exercise | A | 0.93 | 20,000 | 18,600 | 20,000 | |
| Aug 17 2004 | GEB | INOVIO PHARMACEUTI ... | HEPPELL JAMES L | Director | Option Exercise | A | 0.93 | 20,000 | 18,600 | 20,000 | |
| Aug 17 2004 | GEB | INOVIO PHARMACEUTI ... | ESMAIL TAZDIN | Director | Option Exercise | A | 0.93 | 20,000 | 18,600 | 20,000 | |
| Jun 30 2004 | GEB | INOVIO PHARMACEUTI ... | ESMAIL TAZDIN | Director | Option Exercise | A | 1.33 | 35,000 | 46,550 | 35,000 | |
| Jun 30 2004 | GEB | INOVIO PHARMACEUTI ... | LARSON EUGENE A | Director | Option Exercise | A | 1.33 | 35,000 | 46,550 | 35,000 | |
| Jun 30 2004 | GEB | INOVIO PHARMACEUTI ... | THEEUWES FELIX | Director | Option Exercise | A | 1.33 | 35,000 | 46,550 | 35,000 | |
| Jun 30 2004 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 1.33 | 35,000 | 46,550 | 35,000 | |
| Jun 30 2004 | GEB | INOVIO PHARMACEUTI ... | HEPPELL JAMES L | Director | Option Exercise | A | 1.33 | 35,000 | 46,550 | 35,000 |